Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trial.
EBioMedicine
View this publicationEBioMedicine
View this publicationJAMA
View this publicationThe Journal of infection
View this publicationNature immunology
View this publicationHGG advances
View this publicationCritical care (London, England)
View this publicationInternational journal of cancer
View this publicationCellular immunology
View this publicationJournal of the European Academy of Dermatology and Venereology : JEADV
View this publicationThe Journal of infectious diseases
View this publication